Terms: = Kidney tumors AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
10 results:
1. DPP9 Stabilizes nrf2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma.
Chang K; Chen Y; Zhang X; Zhang W; Xu N; Zeng B; Wang Y; Feng T; Dai B; Xu F; Ye D; Wang C
Cancer Res; 2023 Dec; 83(23):3940-3955. PubMed ID: 37713596
[TBL] [Abstract] [Full Text] [Related]
2. The deubiquitylating enzyme USP35 restricts regulated cell death to promote survival of renal clear cell carcinoma.
Wang S; Wang T; Zhang X; Cheng S; Chen C; Yang G; Wang F; Wang R; Zhang Q; Yang D; Zhang Y; Liu S; Qin H; Liu Q; Liu H
Cell Death Differ; 2023 Jul; 30(7):1757-1770. PubMed ID: 37173391
[TBL] [Abstract] [Full Text] [Related]
3. YAP-Activated SATB2 Is a Coactivator of nrf2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma.
Jin J; Chen F; He W; Zhao L; Lin B; Zheng D; Chen L; He H; He Q
Cancer Res; 2023 Mar; 83(5):786-803. PubMed ID: 36598364
[TBL] [Abstract] [Full Text] [Related]
4. The Association of Polymorphisms in
Mihailovic S; Coric V; Radic T; Radojevic AS; Matic M; Dragicevic D; Djokic M; Vasic V; Dzamic Z; Simic T; Hadzi-Djokic J; Pljesa Ercegovac M
Oxid Med Cell Longev; 2021; 2021():6617969. PubMed ID: 33953831
[TBL] [Abstract] [Full Text] [Related]
5. Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers.
Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
[TBL] [Abstract] [Full Text] [Related]
6. BMP8A promotes survival and drug resistance via nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma.
Yu YP; Cai LC; Wang XY; Cheng SY; Zhang DM; Jian WG; Wang TD; Yang JK; Yang KB; Zhang C
Cancer Sci; 2020 May; 111(5):1555-1566. PubMed ID: 32128917
[TBL] [Abstract] [Full Text] [Related]
7. Glutathione transferase genotypes may serve as determinants of risk and prognosis in renal cell carcinoma.
Pljesa-Ercegovac M; Savic-Radojevic A; Coric V; Radic T; Simic T
Biofactors; 2020 Mar; 46(2):229-238. PubMed ID: 31483924
[TBL] [Abstract] [Full Text] [Related]
8. Downregulation of Keap1 contributes to poor prognosis and Axitinib resistance of renal cell carcinoma via upregulation of nrf2 expression.
Huang H; Wu Y; Fu W; Wang X; Zhou L; Xu X; Huang F; Wu Y
Int J Mol Med; 2019 May; 43(5):2044-2054. PubMed ID: 30896860
[TBL] [Abstract] [Full Text] [Related]
9. Commentary on: "Comprehensive molecular characterization of papillary renal-cell carcinoma." Cancer Genome Atlas Research Network.: N Engl J Med. 2016 Jan 14;374(2):135-45.
Lee BH
Urol Oncol; 2017 Sep; 35(9):578-579. PubMed ID: 28780132
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.
; Linehan WM; Spellman PT; Ricketts CJ; Creighton CJ; Fei SS; Davis C; Wheeler DA; Murray BA; Schmidt L; Vocke CD; Peto M; Al Mamun AA; Shinbrot E; Sethi A; Brooks S; Rathmell WK; Brooks AN; Hoadley KA; Robertson AG; Brooks D; Bowlby R; Sadeghi S; Shen H; Weisenberger DJ; Bootwalla M; Baylin SB; Laird PW; Cherniack AD; Saksena G; Haake S; Li J; Liang H; Lu Y; Mills GB; Akbani R; Leiserson MD; Raphael BJ; Anur P; Bottaro D; Albiges L; Barnabas N; Choueiri TK; Czerniak B; Godwin AK; Hakimi AA; Ho TH; Hsieh J; Ittmann M; Kim WY; Krishnan B; Merino MJ; Mills Shaw KR; Reuter VE; Reznik E; Shelley CS; Shuch B; Signoretti S; Srinivasan R; Tamboli P; Thomas G; Tickoo S; Burnett K; Crain D; Gardner J; Lau K; Mallery D; Morris S; Paulauskis JD; Penny RJ; Shelton C; Shelton WT; Sherman M; Thompson E; Yena P; Avedon MT; Bowen J; Gastier-Foster JM; Gerken M; Leraas KM; Lichtenberg TM; Ramirez NC; Santos T; Wise L; Zmuda E; Demchok JA; Felau I; Hutter CM; Sheth M; Sofia HJ; Tarnuzzer R; Wang Z; Yang L; Zenklusen JC; Zhang J; Ayala B; Baboud J; Chudamani S; Liu J; Lolla L; Naresh R; Pihl T; Sun Q; Wan Y; Wu Y; Ally A; Balasundaram M; Balu S; Beroukhim R; Bodenheimer T; Buhay C; Butterfield YS; Carlsen R; Carter SL; Chao H; Chuah E; Clarke A; Covington KR; Dahdouli M; Dewal N; Dhalla N; Doddapaneni HV; Drummond JA; Gabriel SB; Gibbs RA; Guin R; Hale W; Hawes A; Hayes DN; Holt RA; Hoyle AP; Jefferys SR; Jones SJ; Jones CD; Kalra D; Kovar C; Lewis L; Li J; Ma Y; Marra MA; Mayo M; Meng S; Meyerson M; Mieczkowski PA; Moore RA; Morton D; Mose LE; Mungall AJ; Muzny D; Parker JS; Perou CM; Roach J; Schein JE; Schumacher SE; Shi Y; Simons JV; Sipahimalani P; Skelly T; Soloway MG; Sougnez C; Tam A; Tan D; Thiessen N; Veluvolu U; Wang M; Wilkerson MD; Wong T; Wu J; Xi L; Zhou J; Bedford J; Chen F; Fu Y; Gerstein M; Haussler D; Kasaian K; Lai P; Ling S; Radenbaugh A; Van Den Berg D; Weinstein JN; Zhu J; Albert M; Alexopoulou I; Andersen JJ; Auman JT; Bartlett J; Bastacky S; Bergsten J; Blute ML; Boice L; Bollag RJ; Boyd J; Castle E; Chen YB; Cheville JC; Curley E; Davies B; DeVolk A; Dhir R; Dike L; Eckman J; Engel J; Harr J; Hrebinko R; Huang M; Huelsenbeck-Dill L; Iacocca M; Jacobs B; Lobis M; Maranchie JK; McMeekin S; Myers J; Nelson J; Parfitt J; Parwani A; Petrelli N; Rabeno B; Roy S; Salner AL; Slaton J; Stanton M; Thompson RH; Thorne L; Tucker K; Weinberger PM; Winemiller C; Zach LA; Zuna R
N Engl J Med; 2016 Jan; 374(2):135-45. PubMed ID: 26536169
[TBL] [Abstract] [Full Text] [Related]
